The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of colorectal cancer subtypes identified through iterative clustering to predict response to therapy.
Andreas Schlicker
Research Funding - AstraZeneca
Garry Beran
Employment or Leadership Position - AstraZeneca
Christine M Chresta
Employment or Leadership Position - AstraZeneca
Gael McWalter
Employment or Leadership Position - AstraZeneca
Alison Pritchard
Employment or Leadership Position - AstraZeneca
Susie Weston
Employment or Leadership Position - AstraZeneca
Sarah Runswick
Employment or Leadership Position - AstraZeneca
Sara Davenport
Employment or Leadership Position - AstraZeneca
Kerry Heathcote
Employment or Leadership Position - AstraZeneca
Denis Alferez Castro
Employment or Leadership Position - AstraZeneca
George Orphanides
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Tim French
Employment or Leadership Position - AstraZeneca
Lodewyk F A Wessels
Research Funding - AstraZeneca